Boston Scientific to Engage at UBS Global Healthcare Conference
Boston Scientific Corporation (NYSE: BSX) is set to participate in a significant upcoming event known as the UBS Global Healthcare Conference. This occasion highlights the company’s ongoing commitment to advancing medical technologies that enhance patient care worldwide.
Conference Highlights and Details
During the conference, scheduled for a Tuesday in mid-November, Boston Scientific will present insightful discussions led by key company figures. The participants include Nick Spadea-Anello, President of Electrophysiology, and Jon Monson, Senior Vice President of Investor Relations. Their session is expected to include a 35-minute question-and-answer segment, providing valuable insights for attendees.
Each participant will contribute their knowledge to engage with analysts, shedding light on the innovative strides Boston Scientific is making in the medical field. This live session will commence around 7:15 AM PT, around 10:15 AM ET, and will be available to those who wish to tune in.
Accessing the Live Webcast
A live webcast of this session will be accessible for those unable to attend in person, ensuring that interested parties can still engage with the information shared. Following the event, a replay will be available about an hour after the session concludes, allowing listeners to catch up on any missed discussions.
About Boston Scientific
Boston Scientific stands out in the medical technology field by transforming lives through pioneering solutions aimed at improving healthcare outcomes. With over 45 years of experience, the company has established itself as a global leader, developing a diverse portfolio designed to address various medical needs.
The company specializes in providing high-performance solutions that cover complex conditions across multiple specialties including cardiovascular, respiratory, gastrointestinal, oncology, neurology, and urology. Boston Scientific’s commitment to enhancing healthcare is evident through its range of innovative products designed to elevate patient treatment standards while aiming to reduce healthcare costs.
Innovative Medical Technologies
Boston Scientific's technologies are essential tools for healthcare providers. Their devices and therapies assist healthcare professionals in diagnosing and treating various diseases, directly impacting patient health outcomes. As the industry evolves, so does Boston Scientific, continually seeking to meet the unmet needs of patients through effective innovations.
Contacts for More Information
For further inquiries, you may contact: Chanel Hastings, Media Relations at +1 (508) 382-0288. Another key contact in Investor Relations is Jon Monson who can be reached at +1 (508) 683-5450.
Engaging with Boston Scientific through their official channels provides additional insights into their innovative products and ongoing projects. This engagement is crucial for staying updated with the company’s advancements and contributions to healthcare.
Frequently Asked Questions
What is the purpose of the UBS Global Healthcare Conference?
The conference serves to bring together healthcare professionals, investors, and key opinion leaders to discuss innovations and developments in the medical technology sector.
Who from Boston Scientific will be speaking at the conference?
Boston Scientific’s participants include Nick Spadea-Anello and Jon Monson, who will share insights into the company’s innovative healthcare solutions.
How can I access the live session of the conference?
The live session will be available via a webcast accessible through Boston Scientific's investor relations page.
What types of medical conditions does Boston Scientific address?
Boston Scientific’s technologies span various medical conditions, including cardiovascular, respiratory, gastrointestinal, and more, providing comprehensive solutions for healthcare providers.
How can I get in touch with Boston Scientific for more information?
You can reach out to their media relations team or investor relations department for any inquiries regarding the company and its innovative medical technologies.